Availability of NT-proBNP testing
· How many Community Diagnostic Centres are currently operational in your area? – This information
Is not centrally recorded.
· Is NT-proBNP testing for suspected heart failure currently available within local Community Diagnostic Centres? (please specify if any local Community Diagnostic Centres do not offer NT-proBNP testing) No
· If NT-proBNP testing for suspected heart failure is not currently available, are there any plans to introduce it in future? - This information Is not centrally recorded.
Testing Volume
· How many NT-proBNP blood tests have been performed by the local Community Diagnostic Centre between
January 2021 to August 2024? - None
· How many BNP blood tests have been performed by the local Community Diagnostic Centre between January 2021
to August 2024? - None
· How many patients with a suspected diagnosis of heart failure have accessed the local Community Diagnostic
Centre between January 2021 to August 2024? - This information Is not centrally recorded.
Guidelines - This information Is not centrally recorded.
· What guidelines are in place for the local Community Diagnostic Centre to follow in relation to administering BNP
and or NT-proBNP tests for patients with a suspected diagnosis of heart failure?
· What referral pathways should be followed by the local Community Diagnostic Centre in relation to patients with
a suspected diagnosis of heart failure?
Targets/metrics - This information Is not centrally recorded.
· What assessment has the local Community Diagnostic Centre made of local population need and the likely demand for BNP and/or NT-proBNP testing for patients with a suspected diagnosis of heart failure?
· Based on local demographics, what assessment has the local Community Diagnostic Centre made of the number of patients with a suspected diagnosis of heart failure that should be seen by the centre on an annual basis?
Scaling up - This information Is not centrally recorded.
· What assessment has the local Community Diagnostic Centre made of the need to increase access to BNP and/or
NT-proBNP testing – including projections of growing need and increases in the number of people at risk of heart
failure?
· What assessment has been made of the barriers that may impact the ability of local Community Diagnostic
Centres to meet future demands for access to BNP and/or NT-proBNP testing?
· What assessment has been made of additional resources required by local Community Diagnostic Centres to meet rising demand for BNP and/or NT-proBNP testing over the next 12 months; 18 months; and 5 years?
· What resource has been allocated to local Community Diagnostic Centres for the acquirement of point of care
testing capabilities and administration of BNP and/or NT-proBNP tests?
We have 2 CDCs in ELHT and neither provide this test.
